Evidence map›Paper›PMID 41206449›Full record

ArticleBMC complementary medicine and therapies2025

Retraction Note: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.

Mustafa T Ardah, Simona S Ghanem, Sara A Abdulla, Guohua Lv, Mohamed M Emara, Katerina E Paleologou, Nishant N Vaikath, Jia-Hong Lu, Min Li, Konstantinos Vekrellis and 2 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Mustafa T ArdahDepartment of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Simona S GhanemNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar.
Sara A AbdullaNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar.
Guohua LvDepartment of Biochemistry, Weill Cornell Medical College, New York, NY, USA.
Mohamed M EmaraBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Katerina E PaleologouDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Nishant N VaikathNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar.
Jia-Hong LuState Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China.
Min LiSchool of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
Konstantinos VekrellisCenter of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece.
David EliezerDepartment of Biochemistry, Weill Cornell Medical College, New York, NY, USA.
Omar M A El-AgnafNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar. oelagnaf@hbku.edu.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41206449
PMCPMC12595608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.